CSL Behring
Product Categories
Pharmaceuticals, Antiplatelet and Anticoagulation Therapies, Atrial Fibrillation

Related Content

News
FDA Approves Kcentra Use in Warfarin Reversal for Patients Undergoing Surgery

December 17, 2013 — CSL Behring announced that Kcentra (Prothrombin Complex Concentrate [Human]) has received U.S. Food ...

Home December 17, 2013
arrow
Technology
FDA Approves Kcentra for the Urgent Reversal of Anticoagulation in Adults with Major Bleeding

April 30, 2013 — The U.S. Food and Drug Administration (FDA) approved Kcentra (prothrombin complex concentrate, human) ...

Home April 30, 2013
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now